PARP1 与WDR5相互作用,增强目标基因识别并促进瘤发生
Yali Qin1, Xiaochuan Dong2, Manman Lu1
1School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Cancer letters
|May 16, 2024
概括
多 (ADP-ribose) 聚合酶-1 (PARP1) 与WDR5相互作用,以调节基因表达和染色素. 联合抑制WDR5和PARP1显著阻碍癌细胞增殖,揭示了新的治疗点.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症研究 癌症研究
背景情况:
- 多 (ADP-ribose) 聚合酶-1 (PARP1) 对于DNA损伤的修复至关重要.
- 在染色体识别和基因表达调节中PARP1的作用需要进一步阐明.
- 了解PARP1与染色质修饰物的相互作用是其非正规功能的关键.
研究的目的:
- 研究PARP1和SET1/MLL复合体之间的相互作用,特别是与WDR5.5的相互作用.
- 确定PARP1对特定基因位置的WDR5结合和基因素甲基化的影响.
- 探索针对癌症中PARP1-WDR5相互作用的治疗潜力.
主要方法:
- 同免疫沉降测定以确认蛋白质相互作用.
- 染色体免疫沉 (ChIP) 来评估特定位点的结合和基因组修饰.
- 细胞增殖试验用于评估WDR5和PARP1抑制的联合作用.
主要成果:
- PARP1直接与WDR5结合,这是SET1/MLL复合物的组成部分.
- 在没有改变全球水平的情况下,PARP1影响局部特定的WDR5结合和H3K4甲基化.
- 抑制WDR5Win部位会破坏PARP1-WDR5的相互作用和目标基因的结合.
- 联合抑制WDR5和PARP1在癌细胞中显示出强大的抗增殖作用.
结论:
- PARP1和WDR5在染色体识别和基因表达方面进行合作.
- 在PARP1招募目标基因时,WDR5 Win位点至关重要.
- 针对PARP1-WDR5轴为癌症治疗提供了一个有希望的策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


